Skip to content
WeighLab

NowPatient vs Invyncible

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

NowPatient

Provider comparison

Readers comparing brand medication pack prices who will confirm the supply length, U.S. eligibility, packaging, and full delivery cost.

Semaglutide / month
Not disclosed
Tirzepatide / month
Not disclosed
Index 60/100 · Grade CChecked October 2026
Check NowPatient pricing Read review

Invyncible

Provider comparison

Cost-first shoppers who want compounded GLP-1 combo programs (with B12/glycine) alongside brand Wegovy/Zepbound on one platform.

Semaglutide / month
$149/mo0.45 mg dose, compounded with glycine + B12
Tirzepatide / month
$180/mo2.5 mg weekly, 4-week program, compounded
Index 59/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Invyncible pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

NowPatient has the higher Cost-Efficiency Index: 60/100 versus 59/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

NowPatient
Coverage not published
Invyncible
46 states plus DC

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

NowPatient

Invyncible

Semaglutide / month
NowPatient: Not disclosed
Invyncible: $149/mo0.45 mg dose, compounded with glycine + B12
Tirzepatide / month
NowPatient: Not disclosed
Invyncible: $180/mo2.5 mg weekly, 4-week program, compounded
Semaglutide / year (modeled)
NowPatient: —
Invyncible: $1,788
Tirzepatide / year (modeled)
NowPatient: —
Invyncible: $2,160
State availability
NowPatient: Coverage not published
Invyncible: 46 states plus DC
Oral / sublingual option listed
NowPatient: Yes
Invyncible: Yes
Brand-name access listed
NowPatient: Yes
Invyncible: Yes
Provider facts checked
NowPatient: October 2026
Invyncible: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

NowPatient

Readers comparing brand medication pack prices who will confirm the supply length, U.S. eligibility, packaging, and full delivery cost.

Reasons to consider it

  • Public product tables show brand medication pack prices by strength
  • A prescribing clinician assesses eligibility through a free video consultation
  • Named pharmacy and clinical leadership and published delivery policies

What to weigh up

  • Wegovy pens start at $215.98 and Mounjaro KwikPens at $251.98 per listed pen; confirm how many doses each pack contains
  • The pages add $75 shipping and import duties for injectable orders and $20 for Wegovy tablet orders; Core+ delivery waivers have separate terms
  • No U.S. treatment-specific state coverage list is published
Check NowPatient pricing Read the full NowPatient review

Invyncible

Cost-first shoppers who want compounded GLP-1 combo programs (with B12/glycine) alongside brand Wegovy/Zepbound on one platform.

Reasons to consider it

  • Publishes itemized dollar prices for seven compounded programs plus two brand options directly on the site, no signup required, with the mg vial size named in every dose option
  • Sells FDA-approved brand Wegovy ($1,750/mo) and Zepbound ($1,540/mo) alongside compounded options
  • Names all six compounding pharmacies with street addresses and phone numbers and lets the patient choose which one fills the prescription

What to weigh up

  • Every listed price is shown as a discount off a much higher struck-through 'list' price, and the page invites further negotiation — reads as permanent anchor pricing
  • The entry figure is the smallest vial: plain compounded semaglutide runs $192.50, $262.50 and $350 across its three vial sizes, and the FAQ confirms cost rises with dose
  • The six named pharmacies carry no 503A or 503B designation anywhere, and no medical director is named

Compounded drugs are not FDA-approved. Understand the medication options.

Check Invyncible pricing Read the full Invyncible review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

NowPatientInvyncible
Normalized Cost/Month
NowPatient:
45/100
Invyncible:
60/100
Price Transparency
NowPatient:
72/100
Invyncible:
30/100
Nationwide Access
NowPatient:
24/100
Invyncible:
66/100
Formulation Options
NowPatient:
95/100
Invyncible:
79/100
Clinical Oversight
NowPatient:
85/100
Invyncible:
70/100
Contract Flexibility
NowPatient:
55/100
Invyncible:
61/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to NowPatientAlternatives to Invyncible
More provider matchups
CoreAge Rx vs NowPatientCoreAge Rx vs Invyncible
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.